Atara Biotherapeutics
ATRA
ATRA
140 hedge funds and large institutions have $1.06B invested in Atara Biotherapeutics in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 52 increasing their positions, 37 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.1% more ownership
Funds ownership: 4.34% → 4.44% (+0.1%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6% less capital invested
Capital invested by funds: $1.13B → $1.06B (-$65.6M)
Holders
140
Holding in Top 10
3
Calls
$1.76M
Puts
$778K
Top Buyers
| 1 | +$28.2M | |
| 2 | +$18.6M | |
| 3 | +$9.86M | |
| 4 |
Morgan Stanley
New York
|
+$6.9M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$5.53M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$7.16M | |
| 3 | -$6.45M | |
| 4 |
SPC
Slate Path Capital
New York
|
-$6.12M |
| 5 |
Goldman Sachs
New York
|
-$4.69M |